A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relap
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Andrzej Hellmann Tadeusz Robak John C. Byrd Peter Hillmen |
| Publication date | August 8, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |